Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Nocentini

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Advances in Experimental Medicine and Biology|September 18, 2009
GITR: a modulator of immune response and inflammationGiuseppe Nocentini, Carlo Riccardi
European Journal of Immunology|March 17, 2005
GITR: a multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamilyGiuseppe Nocentini, Carlo Riccardi
Expert Opinion on Therapeutic Targets|August 15, 2018
Glucocorticoid-induced TNFR-related gene (GITR) as a therapeutic target for immunotherapyCarlo Riccardi, Simona Ronchetti, Giuseppe Nocentini
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2019
Novel Immune Targets in Melanoma-LetterGiuseppe Nocentini, Luigi Cari, Carlo Riccardi
Immunity, Inflammation and Disease|March 3, 2017
The role of GITR single-positive cells in immune homeostasisGiuseppe Nocentini, Luigi Cari, Graziella Migliorati, et al.
European Journal of Immunology|April 5, 2007
GITR/GITRL: more than an effector T cell co-stimulatory systemGiuseppe Nocentini, Simona Ronchetti, Salvatore Cuzzocrea, et al.
Oncoimmunology|January 9, 2018
Potential effect of tumor-specific Treg-targeted antibodies in the treatment of human cancers: A bioinformatics analysisLuigi Cari, Giuseppe Nocentini, Graziella Migliorati, et al.
Expert Opinion on Therapeutic Patents|November 13, 2015
Modulation of tumor immunity: a patent evaluation of WO2015026684A1Giuseppe Nocentini, Luigi Cari, Simona Ronchetti, et al.
Frontiers in Immunology|August 1, 2024
Editorial: Targeting regulatory cells in cancer: old and new approaches in immunotherapyLuigi Cari, Rosalinda Sorrentino, Billur Akkaya, et al.
Thescientificworldjournal|June 2, 2012
CD8+ T cells: GITR mattersSimona Ronchetti, Giuseppe Nocentini, Maria Grazia Petrillo, et al.
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Advances in Experimental Medicine and Biology|September 18, 2009
GITR: a modulator of immune response and inflammationGiuseppe Nocentini, Carlo Riccardi
European Journal of Immunology|March 17, 2005
GITR: a multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamilyGiuseppe Nocentini, Carlo Riccardi
Expert Opinion on Therapeutic Targets|August 15, 2018
Glucocorticoid-induced TNFR-related gene (GITR) as a therapeutic target for immunotherapyCarlo Riccardi, Simona Ronchetti, Giuseppe Nocentini
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2019
Novel Immune Targets in Melanoma-LetterGiuseppe Nocentini, Luigi Cari, Carlo Riccardi
Immunity, Inflammation and Disease|March 3, 2017
The role of GITR single-positive cells in immune homeostasisGiuseppe Nocentini, Luigi Cari, Graziella Migliorati, et al.
European Journal of Immunology|April 5, 2007
GITR/GITRL: more than an effector T cell co-stimulatory systemGiuseppe Nocentini, Simona Ronchetti, Salvatore Cuzzocrea, et al.
Oncoimmunology|January 9, 2018
Potential effect of tumor-specific Treg-targeted antibodies in the treatment of human cancers: A bioinformatics analysisLuigi Cari, Giuseppe Nocentini, Graziella Migliorati, et al.
Expert Opinion on Therapeutic Patents|November 13, 2015
Modulation of tumor immunity: a patent evaluation of WO2015026684A1Giuseppe Nocentini, Luigi Cari, Simona Ronchetti, et al.
Frontiers in Immunology|August 1, 2024
Editorial: Targeting regulatory cells in cancer: old and new approaches in immunotherapyLuigi Cari, Rosalinda Sorrentino, Billur Akkaya, et al.
Thescientificworldjournal|June 2, 2012
CD8+ T cells: GITR mattersSimona Ronchetti, Giuseppe Nocentini, Maria Grazia Petrillo, et al.
Pageof 9